Funding Details
- Awarder
- YCombinator
- Date Award
- January 26, 2024
- Vertical
- Healthcare,Therapeutics
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2024
- Company Description
- We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. In addition, our drugs have a unique delivery mechanism known as hypoxia-activated prodrugs (HAPs). HAPs are drugs designed to become active in a hypoxic (low oxygen) environment, which is a hallmark of the majority of solid tumors. By delivering active drugs only to the tumor site, we hope to overcome systemic toxicity in cancer therapeutics. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
- Market
- Healthcare
- Location
-
American Fork,
UT,
USA
- Coinvestors
- YCombinator
Links